Incidence of radiation pneumonitis after thoracic irradiation: Dose-volume correlates

International Journal of Radiation Oncology Biology Physics

Volumn 67, Issue 2, 2007, Pages 410-416

  Schallenkamp, John M ^a   Miller, Robert C ^a   Brinkmann, Debra H ^a   Foote, Tyler ^a   Garces, Yolanda I ^a  

^a MAYO CLINIC   (United States)

Author keywords

Dose volume histogram; Lung cancer; Radiation pneumonitis

Indexed keywords

HEALTH RISKS; PATIENT TREATMENT; RADIOTHERAPY; REGRESSION ANALYSIS; TOXICITY; TUMORS;

DOSE VOLUME HISTOGRAMS; INTRATHORACIC RADIOTHERAPY; RADIATION PNEUMONITIS; RECEIVER OPERATING CHARACTERISTIC (ROC);

DOSIMETRY;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER SIZE; CELL HETEROGENEITY; CONTROLLED STUDY; DOSE RESPONSE; DOSIMETRY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; PREDICTION AND FORECASTING; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION PNEUMONIA; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY;

AGED; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIATION PNEUMONITIS; RETROSPECTIVE STUDIES; ROC CURVE; TREATMENT OUTCOME;

EID: 33846239320     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.09.030     Document Type: Article

References (27)

1. Chen Y., Williams J., Ding I., et al. Radiation pneumonitis and early circulatory cytokine markers. Semin Radiat Oncol 12 1 Suppl 1 (2002) 26-33
2. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
3. McDonald S., Rubin P., Phillips T.L., and Marks L.B. Injury to the lung from cancer therapy: Clinical syndromes, measurable endpoints, and potential scoring systems. Int J Radiat Oncol Biol Phys 31 (1995) 1187-1203
4. Rubin P., Johnston C.J., Williams J.P., et al. A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys 33 (1995) 99-109
5. Salinas F.V., and Winterbauer R.H. Radiation pneumonitis: A mimic of infectious pneumonitis. Semin Respir Infect 10 (1995) 143-153
6. Graham M.V., Purdy J.A., Emami B., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45 (1999) 323-329
7. Tsujino K., Hirota S., Endo M., et al. Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 55 (2003) 110-115
8. Schild S.E., Stella P.J., Geyer S.M., et al., North Central Cancer Treatment Group. The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly. J Clin Oncol 21 (2003) 3201-3206 Epub 2003 Jul 21
9. Sause W., Kolesar P., Taylor IV S., et al., Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, Southwest Oncology Group. Final results of a phase III trial in regionally advanced unresectable non-small cell lung cancer. Chest 117 (2000) 358-364
10. Perez C.A., Stanley K., Grundy G., et al. Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung: Report by the Radiation Therapy Oncology Group. Cancer 50 (1982) 1091-1099
11. The Lung Cancer Study Group. Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. N Engl J Med 315 (1986) 1377-1381
12. International Commission on Radiation Units and Measurements. ICRU Report 50: Prescribing, recording, and reporting photon beam therapy (1993), International Commission on Radiation Units and Measurements, Bethesda, MD
13. International Commission on Radiation Units and Measurements. ICRU Report 62: Prescribing, recording, and reporting photon beam therapy (1999), International Commission on Radiation Units and Measurements, Bethesda, MD
14. Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events v. 2.0, NCTD, NCI, NIH, DHHS, April 30, 1999.
15. Burman C., Kutcher G.J., Emami B., and Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 21 (1991) 123-135
16. Fay M., Tan A., Fisher R., et al. Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 61 (2005) 1355-1363
17. DeLong E.R., DeLong D.M., and Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 44 (1988) 837-845
18. Lind P.A., Marks L.B., Hollis D., et al. Receiver operating characteristic curves to assess predictors of radiation-induced symptomatic lung injury. Int J Radiat Oncol Biol Phys 54 (2002) 340-347
19. Rodrigues G., Lock M., D'Souza D., et al. Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer: a systematic review. Radiother Oncol 71 (2004) 127-138
20. Kwa S.L., Lebesque J.V., Theuws J.C., et al. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 42 (1998) 1-9
21. Seppenwoolde Y., Lebesque J.V., de Jaeger K., et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis: Normal tissue complication probability. Int J Radiat Oncol Biol Phys 55 (2003) 724-735
22. Lee H.K., Vaporciyan A.A., Cox J.D., et al. Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: Correlation with pulmonary dose-volume histogram parameters. Int J Radiat Oncol Biol Phys 57 (2003) 1317-1322
23. Ozturk B., Egehan I., Atavci S., and Kitapci M. Pentoxifylline in prevention of radiation-induced lung toxicity in patients with breast and lung cancer: A double-blind randomized trial. Int J Radiat Oncol Biol Phys 58 (2004) 213-219
24. Komaki R., Lee J.S., Milas L., et al. Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: Report of a randomized comparative trial. Int J Radiat Oncol Biol Phys 58 (2004) 1369-1377
25. Komaki R., Lee J.S., Kaplan B., et al. Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: Preliminary results. Semin Radiat Oncol 12 1 Suppl 1 (2002) 46-49
26. Sasse A.D., Clark L.G., Sasse E.C., and Clark O.A. Amifostine reduces side effects and improves complete response rate during radiotherapy: Results of a meta-analysis. Int J Radiat Oncol Biol Phys 64 (2005) 784-791
27. Dorr W., Bassler S., Reichel S., and Spekl K. Reduction of radiochemotherapy-induced early oral mucositis by recombinant human keratinocyte growth factor (palifermin): Experimental studies in mice. Int J Radiat Oncol Biol Phys 62 (2005) 881-887